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Abstract. Oxycodone and morphine are powerful analgesic drugs used for post-operative 
pain management, and no studies have been conducted to get an equianalgesic dose of 
Oxycodone and Morphine. This study was using a double-blind randomized clinical trials, 
48 samples, ages 21-60 years, PS ASA I-II, which will get an elective orthopedic surgery 
using general anesthesia techniques. The drug is given when the patient has 
extubated.  Oxycodone (group A) : Morphine (group B) (Initial 5mg than continuous 1 
mg/hour : initial dose 4mg than continuous 0,5 mg/hour). Average drug dose for group that 
takes morphine and oxycodone  (3.90 ± 0.46 mg : 1.46 ± 0.51 mg).  No significant difference 
between the average dose (p <0.05).  Equianalgesic doses in group Oxycodone and Morphine 
is 1.4 mg: 3.9mg. 
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1. Introduction 
Pain is a subjective feeling or experience that involves sensory, emotional and unpleasant 
behavior associated with tissue damage or potential damage to tissue. If pain is not addressed, it 
can have a negative impact on post-surgical patients such as anxiety (sleep disturbance) 
immunosuppression, hyperglycemia, hemodynamic changes (hypertension, tachycardia), 
decreased breathing movements, causing coughing, fears to move will increase the risk of 
thromboembolic complications and increase catecholamine release leading to increased vascular 
resistance, prolong catabolic phase, decrease blood flow to the inferior extremity and decreases 
the blood circulation to the splanchnic. The most commonly used opioid drug today is morphine 
because of its rapid spontaneous analgesia and also its duration of action. Opioid receptors are 
synthesized and increase in the number of sensory nerves to both central and peripheral, while 
endogenous opioids binding to these receptors cause decreased neural fibers' impaired 
stimulation. 
Oxycodone is an agonist receptor of mu and kappa opioid, structurally similar to codeine, but 
pharmacodynamically similar to morphine. In addition to having analgesia effects, oxycodone 
also causes anxiolysis, euphoria, calm feeling, and cough suppression, as well as respiratory 
depression, constipation, miosis, sweating, and drowsiness. will eventually in-crease the cost of 
treatment. (Morgan, 2013) (Rawal, 2008) (Stoelting, 2006) 
Oxycodone in various preparations has a broad effect to be used as a therapeutic efficacy. 
Morphine is an opioid used to treat severe pain and is used as a reference to the work mechanism 
of other opioid drugs. Morphine should be used with caution against people with renal failure 
because of its active metabolites (morphine-6-glucoronide) that can cause respiratory failure, 
(Misiolek, 2014). 
In 2010, Plante examined that intravenous administration of oxycodone required a 1.5 times 
greater dose than morphine. (Plante, 2010) Oxycodone is an alternative medicine for patients who 
experience side effects against other types of opioids, such as morphine (eg hallucinations), 
conversion factors for other opioids used only as a general guide. Always use a conservative 
approach when switching from one type of opioid to another, in other words, starting from a low 
dose. The estimated conversion ratio between intravenous oxycodone and intravenous morphine 
is 1: 1, ie 1 mg intravenous oxycodone is equivalent to 1 mg of intravenous morphine at a dose 
for each patient must be titrated individually to achieve the optimum dose for pain management. 
(Mundipharma, 2015) 
 
In 1997 at Helsinki, a study was conducted evaluating postoperative pain management with PCA 
in 50 subjects undergoing spine surgery, found to use morphine 45 mcg / kgBW and oxycodone 
30 mcg / kgBW had the same effectiveness in dealing with postoperative pain. (Silvasti, 1998) 
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In 2009 a study of the management of postoperative pain in 91 female subjects undergoing 
laparoscopic hysterectomy surgery. It was found at the same dose of 0.015 mg / kg body weight 
which received oxycodone proved to have a lower VAS compared to morphine. (Lenz, 2009). 
 
In theory, oxycodone is an analgesic alternative to morphine which can be used for postoperative 
pain relief with milder side effects. No studies have been conducted to determine the equivalence 
of doses on the analgesic effect of these two drugs. This research is the first to be done in Asians. 
From some of the studies above, it appears that the dosages used on these two drugs differ. This 
is what underlies the need for a study to find out the equivalence of these two analgesic doses, to 
facilitate the conversion of these two drugs.  
2. Methodology 
Design : The design of this study used randomized controlled and double-blinded clinical trials. 
To determine the equivalence of analgesic doses (equianalgesic doses) oxycodone with 
continuous infusion morphine in overcoming pain with VAS assessment after long bone surgery 
under general anesthesia. 
Time and Place : 
This research was conducted in Haji Adam Malik General Hospital in Medan, North Sumatera. 
The study began on 1st of August 2017 until 25th of September 2017, after the ethical clearance 
and permission from the Haji Adam Malik General Hospital were issued. 
 
Population and Sample : The study sample was a population that fulfilled inclusion and 
exclusion criteria. This sample was di-vided into 2 groups: 
• Group A receives intravenous continuous oxycodone infusion with target VAS value ≤ 3. 
• Group B receives intravenous continuous morphine infusion with target values of VAS ≤3. 
Then the patient is separated by inclusion and exclusion criteria. 
 
Inclusion Criteria: 
1. Aged 21-60 years old 
2. Patients undergoing long bone surgery 
3. Patients with ASA Physical Status 1 and 2 
4. Patients agree to participate in the study 
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Exclusion criteria: Patients who have opioid analgesics prior to surgery 
Drop out criteria: Cardiovascular and pulmonary emergencies, allergic reaction observed after 
the use of the drugs. 
Numbers of sample : From the calculation with the formula, then obtained a sample size of 20 
people plus 20% if there is a test break up to 24 people. So the total sample of the two groups was 
44 people. 
 
Preparation :  
After receiving an explanation of the procedure to be performed and signing an informed consent, 
all samples were measured for PBW (Predicted Body Weight), then the study subjects were 
included in the inclusion and exclusion criteria. 
 
Samples were randomly divided into 2 groups, namely group A received continuous intravenous 
oxycodone infusion and group B received continuous intravenous morphine infusion, then 
randomized double-blind infusion by trained volunteers. Randomization is done by block, each 
sequence consisting of six subjects, with the number of possible combinations of sequences of 
eight. Then the pen is dropped on a random number. Then the sequences obtained are arranged 
sequentially according to the envelope number. 
 
The drug is prepared by volunteers who carry out randomization (researchers do not know the 
composition of the drugs given). To make oxycodone preparations, oxycodone is taken as much 
as 50 mg. then dissolved with 0.9% NaCl to 50 ml, so that each 1 ml solution contains 1 mg of 
oxycodone, connected to the three ways with an extension tube, given with a Syringe Pump, with 
initial administration of 5 mg bolus and an increase in dose of 1 mg / hour (1ml) until the target 
VAS value ≤ 3 is reached. To make morphine preparations, morphine is taken as much as 25 mg 
and then dissolved with 0.9% NaCl solution to 50 ml so that every 1 ml solution contains 0.5 mg 
of morphine, connected to three ways with an extension tube, given with a Syringe Pump, with 
an initial administration of 4 mg and an increase in dose of 0.5 mg / hour (1ml) until the target 
VAS value ≤ 3 is reached. 
 
During the process of increasing the syringe pump dose filled with medicine, it is closed with a 
paper. Only volunteers can take medicine to fill the medicine. 
 
Procedure :  
After the patient arrived in the waiting room of the operating room, the patient was rechecked for 
identity, diagnosis, anesthesia plan, access to infusion (make sure the infusion has been installed 
with 18G abocath, threeway and smooth infusion flow).  
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Then the patient was brought to the operating room, then a standard monitor was installed (ECG, 
blood pressure, heart rate, breathing frequency, oxygen saturation). 
Both groups of patients were given preloading liquid Ringer Lactate 10 ml / kgBW and were 
prepared for general anesthesia then premedication with fentanyl 2 mcg / kg, midazolam 0.05 mg 
/ kg, wait 5 minutes onset. The patients were induced with propofol 2 mg / kg, rocuronium 1 mg 
/ kg, after onset was reached for 1 minute, direct laryngoscopy was performed with a laryngoscope 
and the trachea was intubated with an appropriate endotracheal tube. Surgery began, maintenance 
of sedation using isoflurane, maintenance of analgesia with fentanyl according to the 
hemodynamic response, and maintenance of muscle relaxants using rocuronium. [isoflurane was 
used for sedation maintenace, fentanyl was used for analgesia maintenance according to the 
hemodynamic response, rocuronium was used for muscle relaxants maintenance.] pilih mau yg 
mana kalimatnya yg lebih pas menurut abg 
 
After surgery was done and the patient fulfilled the extubation criteria, the patient was extubated 
and time was recorded as T0, and the VAS was assessed by showing the scale according to the 
pain perception felt by the patient. This assessment was carried out directly by researchers who 
were not involved in administering drugs to the patient. 
 
The time the study began when group A received continuous intravenous oxycodone with an 
initial bolus of 5 cc followed by 1 cc / hour with a target VAS value ≤ 3 for 24 hours, whereas 
group B received continuous intravenous morphine with an initial bolus of 4 mg followed by 0.05 
mg / kg / hr then the dose was increased to 1 cc / hour with a target VAS value ≤ 3 for 24 hours. 
The patient observed in the recovery room and transferred to the treatment room if the Aldrette 
Score is 10. Equality assessment of drug dosages and side effects with a target vase value of ≤ 3 
is carried out directly by the researcher at 0 (T0), 1 (T1), 2 (T2), 3 (T3), 4 (T4), 6 (T5) ), 12 (T6) 
and 24 (T7) after the surgery is over. 
 
The study was stopped if the study subjects refused to participate further, the operation was 
prolonged so that additional general anesthesia was needed, an allergic reaction to oxycodone or 
morphine occurred, and an emergency airway, heart, lung, and brain were threatened. 
 
Results of observational data in the two groups were compared statistically. After the necessary 
data had been collected, then the data is checked again before tabulated and processed. Then the 
data is coded and tabulated into master tables using SPSS software. 
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3. Result 
The study was followed by 48 patients who had met the inclusion criteria, divided into two groups 
with the same number of lots, each totaling 24 people. Patients aged 19-29 years in the morphine 
group were 12 people (50%), while in the oxycodone group were 7 people (29.2%). Patients aged 
30-39 years in the morphine group were 3 people (12.5%), while in the oxycodone group were 2 
people (8.3%). Patients aged 40-49 years in the morphine group were 5 people (20.8%), while in 
the oxycodone group were 6 people (25%). Patients aged 50-59 years in the morphine group were 
4 people (50%), while in the group oxycodone as many as 9 people (37.5%). Based on the age 
characteristics of the patients found relatively homogeneous data (p> 0.05). 
Table 3.1. Distribution of Research Subjects by Age, Gender, and ASA 
Characteristic 
Drugs 
Total p* Value 
Morphine Oxycodone 
1. Age (tahun)     
 19 – 29 12 (50%) 7 (29,2%) 19 (39,6%) 
0,349 
 30 – 39 3 (12,5%) 2 (8,3%) 5 (10,4%) 
 40 – 49 5 (20,8%) 6 (25,0%) 11 (22,9%) 
 50 – 59 4 (16,7%) 9 (37,5%) 13 (27,1%) 
Total 24 (100%) 24 (100%) 48 (100%) 
 
2. Gender     
 Male 13 (54,2%) 15 (62,5%) 28 (58,3%) 
0,558 
 Female 11 (45,8%) 9 (37,5%) 20 (41,7%) 
Total 24 (100%) 24 (100%) 48 (100%) 
 
3. ASA     
 ASA 1 11 (45,8%) 8 (33,3%) 19 (39,6%) 
0,376 
 ASA 2 13 (54,2%) 16 (66,7%) 29 (60,4%) 
Total 24 (100%) 24 (100%) 48 (100%) 
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Based on the table, male subjects in the group that received morphine were 13 people (54.2%) 
and in the group that received oxycodone there were 15 people (62.5%). While female subjects 
who received morphine were 11 people (45.8%) and in the group who received oxycodone there 
were 15 people (62.5%). From the results of the table it can be concluded that the patients in this 
study were relatively homogeneous (p> 0.05). 
 
Subjects with ASA 1 in the group that received morphine were 11 people (45.8%) and in the 
group that received oxycodone there were 8 people (33.3%). While ASA 2 subjects who received 
morphine were 13 people (54.2%) and in the group who received oxycodone there were 16 people 
(66.7%). From the results of the table it can be concluded that the patients in this study were 
relatively homogeneous (p> 0.05). 
 
Table 3.2. Distribution of Research Subjects based on preoperative VAS values 
Pre Op VAS 
Drug 
Total p* Value 
Morphine Oxycodone 
4 14 (58,3%) 11 (45,8%) 25 (52,1%) 
0,386 5 10 (41,7%) 13 (54,2%) 23 (47,9%) 
Total 24 (100,0%) 24 (100,0%) 48 (100,0%) 
 
*Chi-Square Tests 
 
Figure 3.1. Distribution of Research Subjects based on preoperative VAS values 
 
 
Based on the preoperative VAS table, subjects with preoperative VAS 4 in the group who received 
morphine were 14 people (58.3%) and in the group who received oxycodone there were 11 people 
(45.98%). While subjects with preoperative VAS score of 5 who received morphine were 10 
people (41.7%) and in the group who received oxycodone there were 13 people (54.2%). From 
0,0%
15,0%
30,0%
45,0%
60,0%
VAS Pre Op 4 VAS Pre Op 5
58,3%
41,7%
45,8%
54,2%
Morphin
Oxycodone
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the results of the table it can be concluded that the patients in this study were relatively 
homogeneous (p> 0.05). 
 
Table 3.3. Difference in mean duration of surgery based on the drug given 
Drug n 
Duration of Surgery (Minutes) 
p* 
Value 
Mean 
Std. 
Deviation 
Median Minimum Maximum 
Morphine 24 202,92 54,988 200 60 300 
0,583 
Oxycodone 24 191,87 80,997 200 65 365 
 
*t-Test 
The mean duration of operation in the group given the Morphine drug was 202.92 ± 54.99 minutes 
a little longer than the average duration of operation in the group given the oxycodone drug was 
191.87 ± 80.10 minutes. Statistical test with t-test showed no significant difference in operating 
time between the two groups of study subjects (p> 0.05). 
 
Table 3.4. The difference in average time to reach VAS value of 3 based on the drugs given. 
Drug n 
Time to reach VAS value of 3 (Hour) 
p* Value 
Mean 
Std. 
Deviation 
Median Minimum Maximum 
Morphine 24 2,13 0,68 2 1 3 
0,001 
Oxycodone 24 1,46 0,509 1 1 2 
 
*Mann-Whitney test 
The mean time to reach VAS ≤ 3 in morphine group was 2.13 ± 0.68 hours, while the mean time 
to reach VAS ≤ 3 in oxycodone group was 1.46 ± 0.51 hours. Mann-Whitney statistic test showed 
there were significant differences in time to achieve VAS ≤ 3 between the two groups of study 
subjects (p <0.05). 
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Table 3.5. Difference in mean dose of drug based on the drug given 
Drug n 
Dose (mg) 
p* 
Value 
Mean 
Std. 
Deviation 
Median Minimum Maximum 
Morphine 24 3,9021 0,45956 4 3 5 
0,001 
Oxycodone 24 1,4583 0,50898 1 1 2 
 
*Mann-Whitney test 
 
The mean dose of morphine group was 3.90 ± 0.46 mg, while the mean dose of oxycodone group 
was only 1.46 ± 0.51 mg. Statistical tests with the Mann-Whitney test showed there were 
significant differences in the mean drug dose between the two groups of study subjects (p <0.05). 
 
From the statistical test results, the dose range of oxycodone to reach VAS ≤ 3 is 1-2 mg, with an 
average time of 1.46 hours. Morphine dose range to reach VAS ≤ 3 is 3-5 mg with an average 
time of 2.13 hours. The average body weight of the patient was 62.5 kg, so it was obtained about 
the average dose of oxycodone is 0.02 to 0.04 mg/kgBW/hour and the range dose of morphine is 
0.02 s / 0.03 mg / kgBW/hour. 
 
4.  Discussion 
This study assessed the equianalgesic doses of oxycodone and morphine in pain management of 
post-long bones surgery. Research and guidelines for pre-dose equation are limited to single dose 
and opioid rotation, and no similar studies have been conducted in Indonesia or Asia. 
 
Inadequate pain management will cause Metabolic Stress Response (MSR) which will affect all 
body systems and aggravate the patient's condition. This will harm the patient due to physiological 
and psychological changes such as cognitive (central) changes, neurohumoral changes, neural 
plasticity sympathoadrenal activation, and neuroendocrine changes (Sommer, 2008), (Morgan, 
2013). 
 
Pain if not treated properly will result in chronic pain. Jane in 2008 explained that chronic pain 
can be in the form of hyperalgesia and allodynia which treatment for this type of pain is very 
difficult so that treatment for acute pain must be as good as possible to prevent the onset of chronic 
pain. This study is devoted to the management of post-surgical pain which is a problem for 
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patients because after the effects of anesthetic drugs are gone, sufferers will feel pain. The use of 
adequate post-surgical analgesic drugs is important so that chronic pain and emotional 
disturbances do not occur. Quality pain management has a role to help speed up the healing 
process. 
 
This study was followed by 48 samples that met the inclusion criteria. The sample was divided 
into two groups. Group 1: 24 samples that received intravenous morphine with an initial bolus of 
4 mg continued with a dose of 0.05 mg / kgBB / hour continuously with an increase in dose of 
0.5 mg / hour until VAS ≤ 3 was reached. Group 2: from 24 samples who received intravenous 
oxycodone with an initial bolus of 5 mg followed by a continuous 1mg / hour dose with 1mg / h 
dose increase until VAS ≤ 3 was reached. 
 
From the characteristics of the sample data it can be seen that the age between the two groups of 
samples there is no statistically significant difference, thus the sample taken is relatively 
homogeneous (p> 0.05). Similarly, the gender, ASA physical status, VAS Pre op  and duration of 
operation between the two sample groups were not statistically significant (p> 0.05). Based on 
the age characteristics of the patients found relatively homogeneous data. (p> 0.05) 
 
Statistical test results of the average time difference to reach VAS ≤ 3 based on the drug given 
was found that the average time in the morphine group was 2.13 ± 0.68 hours longer than the 
average time in the oxycodone group with 1.46 ± 0.51 hours. The results of the Mann Whitney 
Test statistic showed that there were significant differences between the two groups (p <0.05). 
 
Based on statistical tests on the average dose used to achieve VAS ≤ 3, it was found that the 
average dose of the group of drugs given morphine was 3.90 ± 0.46 mg more than the group given 
oxycodone as much as 1.46 ± 0.51 mg. Statistical tests with the MANN Whitney Test showed 
significant differences between the two groups (p <0.05). 
 
Based on the theory presented by Kalso (2007), pharmacologically oxycodone is a μ-receptor 
agonist, but has a lower affinity than morphine. Oxycodone itself also binds to opiate κ and σ 
receptors, while morphine predominantly binds to μ opiate receptors. The μ and σ receptors are 
known to play a role in the analgesic effect of opiates, while the role of the κ receptor is also 
meaningful but it still requires further in vitro research. This oxycodone bond to the μ, κ and σ 
opiate receptors which mediates the analgesic effect of oxycodone so that it is effective in 
relieving postoperative pain. This might result in a significant difference from the average dose 
used to achieve VAS ≤ 3, where oxycodone has a lower average dose than morphine. 
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The results of the Mann Whitney Test statistic on the average dose used to achieve VAS ≤ 3 also 
showed that the mean (mean) dose used in the morphine group was 3.9021 mg while in the 
oxycodone group was 1.4583 mg. The pharmacology of oxycodone acting on the μ, κ and σ 
receptors, albumin bonds are higher than morphine, and differences in metabolic processes may 
be the cause of the average use of oxycodone doses lower than morphine. 
 
Eastern Metropolitan in 2010 explained that the administration of morphine 10 mg parenterally 
has the same effect as oxycodone 10 mg. Research conducted by Choi in 2016 explained that the 
equivalent dose between oxycodone and morphin is equal to 10 mg. Byung in 2016 examined the 
potential ratio of morphine and oxycodone, which found an equivalent morphine and oxycodone 
intravenously is 1: 1. Another study conducted by Kalso (1991) of 109 research subjects 
comparing oxycodone and intravenous morphine as analgesic drugs after laparoscopic 
hysterectomy surgery with the potential comparison results between oxycodone and intravenous 
morphine with PCA was 2: 3. 
 
The difference in the results of this study is due to differences in the treatment of oxycodone and 
morphine, namely in this study continuous infusion was used, whereas in other studies using only 
a single bolus injection of oxycodone or morphine drugs. In addition, in this study, the purpose 
of using this analgesic drug was to achieve a VAS value of ≤ 3 whereas in other studies only 
assessed the effectiveness of oxycodone as a substitute for opiate analgesic drugs that are often 
used. In the Kalso (1991) study no VAS was assessed so the subjectivity of this study was high. 
 
The results of this study are equalization of continuous intravenous infusion doses between the 
two drugs. This study did not assess the occurrence of side effects that occurred from the two 
drugs. Increasing the dose of opiate medications increases the risk for side effects from opiates. 
Future studies using opiates should assess the side effects that occur in accordance with the dose 
given. 
 
Conclusion 
 
From the results of this research that have been carried out on the value of VAS in 
measuring the equivalent dose (equianalgesic doses) in patients after long bone surgery 
by comparing the administration of oxycodone and morphine can be concluded: 
 
1. There is an equivalent dose (equianalgesic doses) in the oxycodone and morphine 
groups. Continuous intravenous infusion of 1.4 mg of oxycodone and 3.9 mg of 
morphine is effective in dealing with pain after long bone surgery.  
 
2. The time needed to achieve a ≤ 3 VAS value after long bone surgery was shorter in 
the oxycodone group (mean 1.46 hours) compared to the morphine group (average 
2.13 hours). 
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Suggestion 
 
1. Administration of intravenous bolus of 5 mg oxycodone followed by 0.02-0.04 mg/ 
kg/hr continuous infusion of oxycodone can be used to treat pain following long bone 
surgery. 
2. Further research is needed regarding the use of intravenous bolus of 5 mg oxycodone 
followed by 0.02-0.04 mg/kg/hr continuous infusion of oxycodone in various types of 
operations. 
3. Further research is needed to be done on the equivalence of dosages and side effects 
that can occur in the use of this drug. 
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